EE205 Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.454
https://www.valueinhealthjournal.com/article/S1098-3015(22)00655-6/fulltext
Title : EE205 Cost-Effectiveness Analysis of Empagliflozin Versus Albiglutide Among Individuals with Type 2 Diabetes in the US
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00655-6&doi=10.1016/j.jval.2022.04.454
First page :
Section Title :
Open access? : No
Section Order : 10397
Categories :
Tags :
Regions :
ViH Article Tags :